skip to main content
Main Site Navigation
Top of main content
Redefining DigestiveCare Around You.
Filming this video took place prior to COVID-19 pandemic
WATCH VIDEO
AUDIO DESCRIPTIONS

Research and Clinical Trials

At Carle, we understand the importance of research and the role research plays in providing quality care to our patients. Research initiatives offer new information about how to combat disease, show new ways of thinking about treatment and possible cures. Carle physicians also partner with scientists at the University of Illinois to study evolving fields in the science of microbiomes, inflammatory bowel disease, C diff, constipation, and other gut related illnesses.

Carle Digestive Health physicians are involved in many ongoing clinical research studies and clinical trials for Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.

Our skilled physicians are invested in this research to further understand these chronic, sometimes debilitating gastrointestinal (GI) diseases and conditions. To learn more about digestive health research, visit our list of clinical trials or call (844) 37-RESEARCH (844-377-3732) or email us.

Effects of Alcohol After Bariatric Surgery (RBA)

The investigators wish to study the effects of three forms of bariatric surgery: gastric bypass, sleeve gastrectomy, and lap banding. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre- and post-surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body; 2) the effects of alcohol on blood sugar; and 3) the effects of alcohol on mood.

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection

This multicenter, randomized, double-blinded, placebo-controlled study will evaluate the effect of TU-100 on resolution of postoperative ileus (POI) in subjects undergoing open or laparoscopic bowel resection (BR).

SEE MORE CLINICAL TRIALS

Meet Our Team

With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.

MEET OUR TEAM

Giving

Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for digestive health patients and their loved ones. With your support, we’ll expand the scope of services offered and further Carle’s dedication to the diagnosis and treatment of digestive issues.

DONATE NOW LEARN MORE

Related Events

Sep. 7, 2022
6 p.m.
Sep. 21, 2022
6 p.m.
Oct. 5, 2022
6 p.m.

Awards and Accreditations

Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.

    • Commission on Cancer - Certified Rectal Cancer Facility
    • National Association for Gastrointestinal Endoscopy